FDA approves Idhifa to treat relapsed acute myeloid leukemia
Tuesday, August 1, 2017 - 13:52
in Health & Medicine
The U.S. Food and Drug Administration today approved a new drug, Idhifa, to treat adults with relapsed or refractory acute myeloid leukemia.